[EWTX] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[EWTX] Edgewise Therapeutics, Inc.
Announcement Date
22-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- -550.54%
Quarter Report
EWTX's Result
EWTX's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
Revenue 0 0 0 0 0 -
PBT -100,163 -19,415 -42,813 -17,123 -9,705 79.16%
Tax 0 -4,018 -674 -69 -219 -
NP -100,163 -15,397 -42,139 -17,054 -9,486 80.19%
Tax Rate - - - - - -
Total Cost 100,163 15,397 42,139 17,054 9,486 80.19%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
EPS -1.57 -0.29 -0.85 -0.35 -0.19 69.48%
EPS Diluted -1.57 -0.29 -0.85 -0.35 -0.19 69.48%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.